SOUTH SAN FRANCISCO, Calif., Sept. 1, 2011 /PRNewswire/ —
diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company
focused on the development and commercialization of
patent-protected in vitro diagnostic products addressing
unmet needs in cardiovascular disease, today said that it plans to
present at Baird’s 2011 Health Care Conference on Thursday,
September 8, 2011 at 9:30 am Eastern Time (6:30 am Pacific Time) at
the New York Palace Hotel in New York City, NY.  James Panek,
Interim Chief Executive Officer, and Brian E. Ward, Interim Chief
Operating Officer, will provide a corporate overview.  To
access the live webcast and the subsequent archived recording of
the presentation, please log onto diaDexus’ website at www.diadexus.com/webcast.

About diaDexus, Inc.

diaDexus, Inc., based in South San Francisco, California, is
focused on the development and commercialization of
patent-protected in vitro diagnostic products addressing
unmet needs in cardiovascular disease.  The company’s PLAC
ELISA Test for Lp-PLA2 is the only blood test cleared by the FDA to
aid in assessing risk for both coronary heart disease and ischemic
stroke associated with atherosclerosis. For more information,
please visit the company’s website at www.diaDexus.com

‘/>”/>

SOURCE